High glucosamine-phosphate N-acetyltransferase 1 (GNPNAT1) expression predicted poor prognosis in lung cancer and breast cancer, but was also observed in radiotherapy-sensitive breast cancer cells (69–71). This evidence concerns the gene GNPNAT1 and lung carcinoma.